Mark Foley

(Mr. Mark Foley)

Currently holds positions in Revance Therapeutics Inc, SI-BONE Inc, ZELTIQ Aesthetics Inc and Revance Therapeutics Inc

Positions

Position Company Period
Independent Director Revance Therapeutics Inc Sept. 5, 2017 -
Independent Director SI-BONE Inc June 17, 2019 -
President, Chief Executive Officer ZELTIQ Aesthetics Inc April 28, 2017 -
President, Chief Executive Officer, Director Revance Therapeutics Inc Oct. 13, 2019 -
Independent Director Revance Therapeutics Inc Sept. 5, 2017 - Oct. 13, 2019
Chairman of the Board, President, Chief Executive Officer ZELTIQ Aesthetics Inc Jan. 1, 2015 - April 28, 2017
President, Chief Executive Officer, Director ZELTIQ Aesthetics Inc Nov. 19, 2012 - Jan. 1, 2015
President, Chief Executive Officer, Interim Chief Financial Officer, Director ZELTIQ Aesthetics Inc Aug. 23, 2012 - Nov. 19, 2012
Interim President, Chief Executive Officer, Interim Chief Financial Officer, Director ZELTIQ Aesthetics Inc Aug. 9, 2012 - Aug. 23, 2012
Interim President and Chief Executive Officer, Director ZELTIQ Aesthetics Inc April 19, 2012 - Aug. 9, 2012
Director ZELTIQ Aesthetics Inc May 1, 2010 - April 19, 2012
Mark Foley's trades of Glaukos Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-28 2025-02-26
US Glaukos Corp (GKOS)
S Sale
20,687 -27.6%
120.72
USD 2,497,335 		20,687 -27.6% 120.72 USD 2,497,335
2024-03-08 2024-03-06
B Purchase
30,000 +3.0%
6.98
USD 209,400 		30,000 +3.0% 6.98 USD 209,400
2024-02-26 2024-02-23
US Glaukos Corp (GKOS)
S Sale
4,560 -12.1%
92.87
USD 423,487 		4,560 -12.1% 92.87 USD 423,487
2023-08-04 2023-08-03
PS Planned sale
26,279 -3.0%
22.57
USD 593,151 		26,279 -3.0% 22.57 USD 593,151
2023-07-05 2023-07-03
PS Planned sale
26,279 -2.9%
24.94
USD 655,333 		26,279 -2.9% 24.94 USD 655,333
2023-06-13 2023-06-09
PS Planned sale
31,279 -3.4%
30.72
USD 960,928 		31,279 -3.4% 30.72 USD 960,928
2023-05-16 2023-05-15
S Sale
70,447 -7.1%
34.55
USD 2,433,725 		70,447 -7.1% 34.55 USD 2,433,725
2023-03-09 2023-03-09
S Sale
70,390 -7.9%
31.59
USD 2,223,360 		70,390 -7.9% 31.59 USD 2,223,360
2021-11-29 2021-11-29
B Purchase
40,000 +56.4%
12.90
USD 515,924 		40,000 +56.4% 12.90 USD 515,924
2016-03-23 2016-03-22
PS Planned sale
9,698 -2.6%
25.01
USD 242,568 		9,698 -2.6% 25.01 USD 242,568
2016-03-22 2016-03-18
PS Planned sale
1,272 -0.3%
25.01
USD 31,816 		1,272 -0.3% 25.01 USD 31,816
// ... existing code ... // ... rest of the file ...